Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.2B bought by 555 insiders at 344 companies
- $9.7B sold by 672 insiders outside a trading plan
- $4.8B sold by 994 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$161M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
NVDANvidia Corporation ComMark A StevensDirector$536M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
DELLDell Technologies Inc.Silver Lake Partners IV, L.P.Director · +4 joint filers$356M
-
DELLDell Technologies Inc.Sl Spv-2, L.P.Director · +4 joint filers$289M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Yunjie Han DirectorZKHZKH Group LimitedSale$775K 9,289,000 shares at $0.0800 86% of stakeTraded Sep 11 Filed Sep 15
-
Gang Ye COOSESea LimitedPlanned sale$4.3M 40,000 shares at $107.72 5.6% of stakeTraded Sep 11–14 Filed Sep 15
-
Shawn T Carolan DirectorCHYMChime Financial, Inc.Sale$19.2M 579,313 shares at $33.13 100% of stakeTraded Sep 10–11 Filed Sep 14
-
Equity Ulc Parallel49 10% owner · +2 joint filersPMTSCPI Card Group Inc.Sale$54.9M 2,687,921 shares at $20.43 100% of stakeTraded Sep 14 Filed Sep 14
-
Jeanne Thoma DirectorANIPANI Pharmaceuticals, Inc.Planned sale$72K 1,000 shares at $71.53 3.6% of stakeTraded Sep 11 Filed Sep 14
-
Meredith Cook Sr. VP, General Counsel & Sec.ANIPANI Pharmaceuticals, Inc.Planned sale$35K 500 shares at $70.79 0.7% of stakeTraded Sep 14 Filed Sep 14
-
Joseph Frank Oldakowski VP of Finance and ControllerCLOVClover Health Investments, Corp.Sale$103K 20,000 shares at $5.16 6.7% of stakeTraded Sep 14 Filed Sep 14
-
Craig F. Courtemanche Jr. ChairPCORProcore Technologies, Inc.Planned sale$3M 56,122 shares at $53.48 5.8% of stakeTraded Sep 10 Filed Sep 14
-
Kendall Larsen CEOVHCVirnetX Holding CorpPlanned sale$232K 20,425 shares at $11.37 5.7% of stakeTraded Sep 10–14 Filed Sep 14
-
Robert Joseph Ball CEOSIShoulder Innovations, Inc.Sale$188K 10,175 shares at $18.45 2.6% of stakeTraded Sep 14 Filed Sep 14
-
Lightspeed Venture Partners Select, L.P. 10% owner · +8 joint filersNTSKNetskope, Inc.Sale$158K 10,621 shares at $14.90 100% of stakeTraded Sep 11 Filed Sep 14
-
Elizabeth A Cook DirectorCMECME Group Inc.Sale$140K 500 shares at $280.11 2.7% of stakeTraded Sep 14 Filed Sep 14
-
Richard J Mark DirectorTHCTenet Healthcare CorporationSale$2.6M 10,000 shares at $263.42 29% of stakeTraded Sep 10 Filed Sep 14
-
Steven B. Binder DirectorMNKDMannKind CorporationPlanned sale$128K 33,558 shares at $3.81 4.3% of stakeTraded Sep 10 Filed Sep 14
-
David P Meeker CEORYTMRhythm Pharmaceuticals, Inc.Planned sale$5.1M 50,000 shares at $102.67 17% of stakeTraded Sep 14 Filed Sep 14
-
Robert Ferrall Lowe III EVP Exploration & ProductionDVNDevon Energy CorporationSale$344K 6,756 shares at $50.95 8.5% of stakeTraded Sep 14 Filed Sep 14
-
Richard Lee Van Kirk Jr. CEOPDEXPro-Dex, Inc.Planned sale$45K 765 shares at $59.36 1% of stakeTraded Sep 11 Filed Sep 14
-
Jonathan R Scott 10% owner · +5 joint filersFIBKFirst Interstate BancSystem, Inc.Sale$301K 8,071 shares at $37.29 1% of stakeTraded Sep 14 Filed Sep 14
-
Daniel James Drobac VP & Chief Accounting OfficerTMUST-Mobile US Inc.Planned sale$138K 772 shares at $178.33 2.2% of stakeTraded Sep 10 Filed Sep 14
-
Thimaya K. Subaiya EVP, OperationsCSCOCisco Systems, Inc.Planned sale$34K 312 shares at $110.18 0.2% of stakeTraded Sep 14 Filed Sep 14
-
Oliver Tuszik EVP, Global SalesCSCOCisco Systems, Inc.Planned sale$75K 680 shares at $110.18 0.4% of stakeTraded Sep 14 Filed Sep 14
-
Mark Patterson CFOCSCOCisco Systems, Inc.Planned sale$195K 1,795 shares at $108.87 1.1% of stakeTraded Sep 11 Filed Sep 14
-
Francis Duhay DirectorNVNOenVVeno Medical CorporationPlanned sale$123 11 shares at $11.21 0.5% of stakeTraded Sep 11 Filed Sep 14
-
Kristen Cunningham Chief Sales OfficerLFVNLifevantage CorporationSale$56K 9,001 shares at $6.18 7% of stakeTraded Sep 11–14 Filed Sep 14
-
David P Tomick DirectorCZRCaesars Entertainment, Inc.Sale$415K 14,000 shares at $29.67 31% of stakeTraded Sep 10–11 Filed Sep 14
-
John C.m. Farquhar CEOHTFLHeartflow, Inc.Planned sale$1.8M 38,900 shares at $46.78 11% of stakeTraded Sep 10–11 Filed Sep 14
-
Ita M Brennan DirectorCDNSCadence Design Systems, Inc.Planned sale$51K 180 shares at $285.51 2.2% of stakeTraded Sep 10 Filed Sep 14
-
Jason Hulse Murray CEOPACSPACS Group, Inc.Planned sale$887K 19,617 shares at $45.19 <0.1% of stakeTraded Sep 10–14 Filed Sep 14
-
Neena M Patil EVP & Chief Legal OfficerJAZZJazz Pharmaceuticals plcPlanned sale$289K 1,200 shares at $240.94 2.5% of stakeTraded Sep 10 Filed Sep 14
-
Venkat Achanta EVP, Chief Tech, Data & Analy.TRUTransUnionSale$1.8M 23,287 shares at $77.00 11% of stakeTraded Sep 10 Filed Sep 14
-
Kumud Kalia Chief Information OfficerGHGuardant Health, Inc.Sale$632K 4,000 shares at $158.05 9.1% of stakeTraded Sep 11 Filed Sep 14
-
Anthony Mancini See RemarksRVMDRevolution Medicines, Inc.Planned sale$3.2M 15,448 shares at $204.16 26% of stakeTraded Sep 10 Filed Sep 14
-
Laurence Denny Chief Legal OfficerEGHT8x8 IncPlanned sale$17K 9,433 shares at $1.82 1.5% of stakeTraded Sep 11 Filed Sep 14
-
Timothy Bergwall SVP, Chief Commercial OfficerGEFGreif, Inc.Planned sale$166K 2,000 shares at $83.14 3.6% of stakeTraded Sep 10 Filed Sep 14
-
Andrew F. Burton DirectorEGHT8x8 IncPlanned sale$194K 107,085 shares at $1.81 41% of stakeTraded Sep 11 Filed Sep 14
-
David Alon Ben Chief Technology OfficerSGHCSuper Group (SGHC) LimitedSale$321K 23,300 shares at $13.79 75% of stakeTraded Sep 14 Filed Sep 14
-
James Feuille DirectorCHYMChime Financial, Inc.Sale$11.6M 351,890 shares at $33.00 91% of stakeTraded Sep 10–11 Filed Sep 14
-
Regina E Groves DirectorATRCAtriCure, Inc.Sale$288K 5,313 shares at $54.22 13% of stakeTraded Sep 11 Filed Sep 14
-
Timothy James Duffin Chief Underwriting OfficerHGHamilton Insurance Group, Ltd.Sale$2M 57,000 shares at $34.61 23% of stakeTraded Sep 10–11 Filed Sep 14
-
Isaiah Fields Chief Legal OfficerAXONAxon Enterprise, Inc.Planned sale$489K 1,017 shares at $480.45 1.8% of stakeTraded Sep 11 Filed Sep 14
-
Andrew Houston CEODBXDropbox, Inc.Planned sale$13.4M 383,800 shares at $35.02 100% of stakeTraded Sep 10 Filed Sep 14
-
Ross Tennenbaum CFODBXDropbox, Inc.Planned sale$3.4M 97,558 shares at $35.02 12% of stakeTraded Sep 10 Filed Sep 14
-
Michael P Donaldson EVP & Chief Legal OfficerEOGEOG Resources, Inc.Sale$1.1M 7,336 shares at $148.00 6.8% of stakeTraded Sep 11 Filed Sep 14
-
Samantha Harnett Chief Legal OfficerLOGILogitech International S.A.Planned sale$1.6M 16,265 shares at $101.35 31% of stakeTraded Sep 11 Filed Sep 14
-
Roy James Kasmar DirectorESNTEssent Group Ltd.Planned sale$332K 4,837 shares at $68.71 19% of stakeTraded Sep 14 Filed Sep 14
-
Jacob Kimball Hawkins CmooFIVEFive Below, Inc.Sale$204K 818 shares at $248.88 18% of stakeTraded Sep 10 Filed Sep 14
-
Sean P. Duffy CEOOMDAOmada Health, Inc.Planned sale$327K 14,960 shares at $21.87 3.8% of stakeTraded Sep 10 Filed Sep 14
-
Steven L. Cook CFOOMDAOmada Health, Inc.Planned sale$149K 6,800 shares at $21.86 3.8% of stakeTraded Sep 10 Filed Sep 14
-
Wei-Li Shao PresidentOMDAOmada Health, Inc.Planned sale$88K 4,036 shares at $21.85 1.3% of stakeTraded Sep 10 Filed Sep 14
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,793 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.